Amato A, Graffagnino C. Continuous cerebral spinal fluid drainage associated with complications in patients admitted with subarachnoid hemorrhage. J Neurosurg. 2013 Oct;119(4):974-80. PMID 23957382). Intermittent drainage is effectively an early, rapid wean performed repeatedly. As such, it might be relevant to look for such studies in your search.
4. The proposed review may still be helpful and the proposed protocol uses different search criteria and methodology than what was used previously, but the authors should be aware of the above studies prior to designing and undertaking an additional review.
5. From the methods, it seems like a meta-analysis is also being planned. This is not clear from the title, abstract, or section 1. If the authors find only 1 RCT, will they simply try to reanalyze the data from a single study? What if those data are no longer available? 6. In the outcomes section, post-shunt placement complications seem to be mixed in with more acute outcomes. This seems to open up another set of questions. How would this be looked at in the setting of reviewed RCTs comparing rapid versus gradual weans? Is the idea to see if VP shunts placed after prompt closure have different complication rates from those placed after a gradual wean? Or is the idea to just look at VP shunt complications in general (seems like a secondary outcome)? 7. Are there other outcomes that might be of interest like length of stay or in-hospital EVD complications?
REVIEWER
david hasan University of Iowa USA REVIEW RETURNED 22-Feb-2019
GENERAL COMMENTS
the authors propose a study to analyze the best management for managing EVD in SAH. I believe the question proposed is of great value but it would be great if the actual analysis was done and included in the manuscript.
VERSION 1 -AUTHOR RESPONSE
This is a protocol proposal for a systematic review to assess randomized clinical trials focused on determining the effect of a rapid versus gradual EVD wean in patients with SAH and an EVD. This is an important topic with potential implications for VP shunt placement rates, length of stay, hospital complications, and patient outcomes. There is only 1 recognized RCT on this question--Klopfenstein et al.--which has been cited as such on multiple occasions in the literature. My main suggestion would be to expand the inclusion criteria so that additional useful studies might be captured by the search. To the reviewer:
We thank you for your thorough examination of this proposal for a systematic review protocol. To our knowledge, a systematic review regarding this scientific issue has to date not been published. We agree that the topic of this review is of great importance as this research field is still sparsely described, and as a systematic review is required before carrying out a clinical trial within the field, we think that this is an important work to do. This is solely a proposal for the protocol for the systematic review and thus we do not yet know which studies will end up in the review after the literature search and screening. Nonetheless, it is a part of this protocol to include observational studies in an appendix describing substantial serious adverse advents, and include these potential studies in the discussion part of the review in case the review reveals only one or a few randomized, clinical trials. We think that as intermittent vs. continuous drainage is a question of the active drain treatment and not the process of drain cessation we think that this study, and others within the same category, seek to answer different questions in relation to drain treatment than does the question of weaning vs. prompt closure which is focused solely on the cessation process of the drain treatment.
4. The proposed review may still be helpful and the proposed protocol uses different search criteria and methodology than what was used previously, but the authors should be aware of the above studies prior to designing and undertaking an additional review. We thank you for this evaluation and we completely agree that a systematic review would be a valuable part of the scientific production describing this specific issue and thank the reviewer for bringing our attention to the above mentioned studies which we find of significant importance. 5. From the methods, it seems like a meta-analysis is also being planned. This is not clear from the title, abstract, or section 1. If the authors find only 1 RCT, will they simply try to reanalyze the data from a single study? What if those data are no longer available?
We have made the appropriate corrections in the manuscript which now include in the title that:"………A protocol for a systematic review with meta-analysis and Trial Sequential Analysis". From the protocol it is now evident that we will perform meta-analysis for the primary and secondary outcomes and that we will not do quantitative (meta-) analysis in a situation when there is only one trial.
6. In the outcomes section, post-shunt placement complications seem to be mixed in with more acute outcomes. This seems to open up another set of questions. How would this be looked at in the setting of reviewed RCTs comparing rapid versus gradual weans? Is the idea to see if VP shunts placed after prompt closure have different complication rates from those placed after a gradual wean? Or is the idea to just look at VP shunt complications in general (seems like a secondary outcome)?
We agree that this is a very important question to clarify in the protocol. We understand that it is a reference to the second point under primary outcomes (page 5) in which it is mentioned that both complications from the external drain treatment and VP shunting will be included as primary outcomes. We use this composite endpoint (SAE) to include the entire course of the treatment (the time with EVD in the acute course and the time with shunt later in the course) to assure that we e.g. do not identify a low EVD infection rate in patients treated with prompt closure, which might translate to a higher rate of shunt infections, or other differences in the acute treatment which could have an affect later. To assess the specific rate of VP shunt implantation and shunt failure (extracted from the SAE prevalence), we have included these variables as primary and secondary outcomes, respectively.
7. Are there other outcomes that might be of interest like length of stay or in-hospital EVD complications? Length of stay in-hospital is a surrogate outcome possibly confounded by different discharge criteria in different hospitals/departments. Furthermore, LOS is a count data outcome which is very rarely normal or Log (normal) distributed, results of meta-analysis of LOS as a continuous outcome may therefore be misleading and we will abstain from pooling LOS data from different trials. It is difficult to associate the outcome of in-hospital EVD complications exclusively to immediate or gradual cessation of drainage without including complications originating from initial surgical or drain complications, we therefore chose not to use in-hospital EVD complications as an outcome. However, we have discussed the matter again in the author group and arguments also exist for including these two measures as secondary outcomes, e.g. if the review suggests that there is no difference between the two treatments, aspects such as hospital LOS and EVD complication rate might be of interest in relation to health care finance and from a patient related perspective. We therefore decided to include these two secondary endpoints and made the appropriate corrections in the manuscript outcome section.
VERSION 2 -REVIEW

REVIEWER
David Chung
Massachusetts General Hospital REVIEW RETURNED 08-Jul-2019
GENERAL COMMENTS
This is a revision of a previously submitted paper that focuses on the plan for a systematic review on a specific aspect of EVD management after subarachnoid hemorrhage. The response to the prior comments are thoughtful and there is no doubt that significant effort has gone into the response; however, much of the response to reviewers does not appear to have been integrated into the revised manuscript, and there remain significant major concerns.
Major comments:
1. I agree with the other reviewer that it makes sense to perform the proposed review and then revise the review protocol into the review itself for this submission.
Answer to the reviewer: Thank you for bringing this methodological issue to our attention. We understand this comment as a recommendation to unite the review protocol with the review itself, and submit the two as one single manuscript. If this is a misinterpretation, we apologize in advance.
Regarding the question of whether a review protocol should be integrated into the review itself and published as one, current PRISMA guidelines (and 2015 PRISMA-P statement) recommend that systematic reviews should build on a separate protocol that describes rationale, hypothesis and planned methods of the review, and that this protocol is made public (besides PROSPERO registration) before data search and extraction is carried out, in order to avoid data driven analysis.
This will in addition make it possible for future peer reviewers and editors to be able to measure the completeness and transparency of the review with a pre-defined methodological approach outlined in an associated protocol. We find this issue of transparency and rigorous methodology of great importance, and we wish to follow these recommendations and seek publication of the review protocol before we carry out the data search, extraction and interpretation of the review.
2. I have to respectfully disagree that "a systematic review regarding this scientific issue has to date not been published." Prior systematic reviews may not be as rigorous and may not follow the same strict guidelines as the proposed review, but that does not mean that they are not reviews.
Answer to the reviewer: We agree on this unfortunate choice of words. By no means has it been our intention to dismiss the existing reviews, and we apologize for the formulation in the previous version of the manuscript. We acknowledge the existing reviews based on thorough literature searches, as well as their individual importance in uncovering this scientific issue.
To our knowledge, previous reviews based on comprehensive literature searches have compared the two common cessation strategies of EVD treatment in patients with hydrocephalus following aneurysmal SAH without pre-published protocols. It is our belief that a review which methodologically meets the rigorous demands for systematic reviews as defined in the PRISMA guidelines (and 2015 PRISMA-P statement) is relevant in order to clarify this very frequent issue within Neuro Intensive Care Units and Neurosurgical Units regarding patients with EVD after SAH. We wish with this review to add to the existing published work in order to provide the highest possible impact for researchers to use in forthcoming work and evaluation of this medical issue.
We have made corrections in the manuscript accordingly, as well as incorporated two references into the manuscript, in section 1.5 regarding the rationale to do this review, in order to underline the eligibility of these studies when evaluating this issue.
3. The authors could integrate answers to some of the prior and current comments into the next revision of the manuscript.
Answer to the reviewer: Thank you for this recommendation. We agree that answers and recommendations from reviewers should be visibly integrated into the revised manuscript. We have revised the manuscript once more and incorporated current and previous recommendations more thoroughly in abstract, section 1.5, 2.4.1, 2.4.6 and in section 3.
4. The authors might want to reconsider the choice not to expand the search criteria.
Answer to the reviewer: We absolutely agree on the importance of investigating the different parts of EVD treatment in a systematic review. We have within the group of authors discussed the previous and current recommendation to expand the search criteria for the review once more, and we agree that the question of intermittent vs. continuous drainage related to outcome, VP-shunt rate and possibly LOS is interesting and very relevant. As we focus on the process of cessation of drain treatment in the present review, and not the drainage treatment itself, we would like to keep the current focus of the review. Cooperation with another research group regarding a systematic review investigating matters related to cessation of EVD treatment would very much be in our interest.
Minor comments:
1. A meta-analysis portion would be great but not necessary.
Answer to the reviewer: Thank you for this suggestion. We have gathered information regarding the planned meta-analysis, please see section 2.4.1.
